We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+9.07%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.86B
AUM Growth
+$161M
Cap. Flow
-$2.69M
Cap. Flow %
-0.09%
Top 10 Hldgs %
25.36%
Holding
465
New
60
Increased
102
Reduced
122
Closed
47

Top Buys

Rank Stock Value
1
CBOE icon
Cboe Global Markets
CBOE
+$33.3M
2
AAPL icon
Apple
AAPL
+$32.7M
3
LSTR icon
Landstar System
LSTR
+$31.2M
4
IT icon
Gartner
IT
+$30.5M
5
BBWI icon
Bath & Body Works
BBWI
+$28.3M

Top Sells

Rank Stock Value
1
SNDK
SANDISK CORP
SNDK
+$54.1M
2
AMG icon
Affiliated Managers Group
AMG
+$31.4M
3
BKNG icon
Booking.com
BKNG
+$26.9M
4
IEX icon
IDEX
IEX
+$25.5M
5
HRL icon
Hormel Foods
HRL
+$21.4M

Sector Composition

Rank Sector Weight
1 Technology 20.76%
2 Healthcare 15.8%
3 Industrials 13.71%
4 Consumer Discretionary 12.79%
5 Consumer Staples 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHX icon
176
DHI Group
DHX
$158M
$1.1M 0.04%
+109,700
New +$1.08M
XOMA
177
DELISTED
Xoma
XOMA
$1.09M 0.04%
15,238
-1,526
-9% -$131K
LUMO
178
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1.09M 0.04%
+3,056
New +$910K
TCRT icon
179
Alaunos Therapeutics
TCRT
$4.84M
$1.09M 0.04%
1,433
-144
-9% -$76.4K
PRTA icon
180
Prothena Corp
PRTA
$468M
$1.09M 0.04%
52,350
+50,880
+3,461% +$1.06M
BGC icon
181
BGC Group
BGC
$4.86B
$979K 0.03%
+166,369
New +$893K
VSTM icon
182
Verastem
VSTM
$615M
$976K 0.03%
8,898
-885
-9% -$95.7K
XLRN
183
DELISTED
Acceleron Pharma
XLRN
$970K 0.03%
24,890
-2,510
-9% -$87.5K
AMSG
184
DELISTED
Amsurg Corp
AMSG
$953K 0.03%
17,417
+4,010
+30% +$204K
SWC
185
DELISTED
Stillwater Mining Co
SWC
$942K 0.03%
63,900
-6,500
-9% -$89.2K
SCAI
186
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$854K 0.03%
+25,390
New +$782K
NTUS
187
DELISTED
Natus Medical Inc
NTUS
$850K 0.03%
+23,590
New +$792K
BAS
188
DELISTED
Basis Energy Services, Inc.
BAS
$841K 0.03%
211
-20
-9% -$126K
SPPI
189
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$838K 0.03%
+120,950
New +$889K
MDGL icon
190
Madrigal Pharmaceuticals
MDGL
$11.9B
$773K 0.03%
8,339
-830
-9% -$85.8K
INO icon
191
Inovio Pharmaceuticals
INO
$76.1M
$749K 0.03%
6,799
-684
-9% -$83.6K
LXRX icon
192
Lexicon Pharmaceuticals
LXRX
$1.07B
$735K 0.03%
+115,409
New +$930K
USNA icon
193
Usana Health Sciences
USNA
$265M
$731K 0.03%
+14,260
New +$700K
BCC icon
194
Boise Cascade
BCC
$2.96B
$729K 0.03%
19,615
-1,486
-7% -$51.2K
NAVG
195
DELISTED
Navigators Group Inc
NAVG
$718K 0.03%
19,586
-1,800
-8% -$62.1K
HPTX
196
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$698K 0.02%
29,100
-2,900
-9% -$65.4K
SYKE
197
DELISTED
SYKES Enterprises Inc
SYKE
$695K 0.02%
29,619
-2,281
-7% -$51K
AFFX
198
DELISTED
Affymetrix Inc
AFFX
$668K 0.02%
67,770
+62,270
+1,132% +$544K
IMGN
199
DELISTED
Immunogen Inc
IMGN
$597K 0.02%
97,860
-9,410
-9% -$86.1K
ALJ
200
DELISTED
Alon USA Energy Inc
ALJ
$591K 0.02%
+46,711
New +$671K
6 7
8
9 10

Similar funds

M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
QT
Quantbot Technologies New York $2.44B AUM 17.13% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
KFA
Krane Funds Advisors New York $2.44B AUM 12.99% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Smith Group Asset Management's Q4 2014 Portfolio in Review

As of Q4 2014, Smith Group Asset Management held 465 positions worth $2.86B, up 6% from $2.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Smith Group Asset Management's Q4 2014 filing shows 60 new, 102 increased, 122 reduced and 47 closed positions. Its largest new stake was Cboe Global Markets: 558,100 shares worth $35.4M. The largest sale was SANDISK CORP, an estimated $54.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

  • Smith Group Asset Management's largest Q4 2014 buy was Cboe Global Markets: 558,100 shares worth $35.4M.
  • Smith Group Asset Management added most to Apple in Q4 2014, an estimated $32.7M increase.
  • Smith Group Asset Management's biggest Q4 2014 reduction was Kimberly-Clark, cutting an estimated $15.6M.
  • Smith Group Asset Management fully exited SANDISK CORP in Q4 2014, selling an estimated $54.1M.
  • Smith Group Asset Management's ten largest holdings make up 25% of its $2.86B portfolio in Q4 2014.
  • Smith Group Asset Management opened 60 new positions and closed 47 in Q4 2014.
  • Smith Group Asset Management's portfolio value rose 6% quarter-over-quarter to $2.86B.

Based on Smith Group Asset Management's 13F filing for Q4 2014, filed 27 Jan 2015.